Familial hypercholesterolemia 2 ▲ Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)

Last Posted: Jan-18-2017 6AM

 Familial Hypercholesterolemia expanded expanded

Familial Hypercholesterolemia: personalized public health epitomized[PDF 2.08 MB]
Josh Knowles, NCI precision medicine & population health webinar, slide presentation, December 14, 2016 

[Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document].
Mata Pedro et al. Atencion primaria 2015 Jan 47(1) 56-65

A Web-Based Registry for Familial Hypercholesterolaemia.
Napier Kathryn R et al. Heart, lung & circulation 2016 Nov

More information on this topic

Last Posted: Jan 12, 2017

---

• [Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document].
  Mata Pedro et al. Atencion primaria 2015 Jan 47(1) 56-65
• A Web-Based Registry for Familial Hypercholesterolaemia.
  Napier Kathryn R et al. Heart, lung & circulation 2016 Nov
• Younger Adults With Severe Dyslipidemia Less Likely to Be Prescribed Statins 
  TCTMD, January 5, 2017
• An Evidence-Based Guide to Cholesterol-Lowering Guidelines.
  Waters David D et al. The Canadian journal of cardiology 2016 Oct
• Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapy.
  Glueck Charles J et al. Lipids in health and disease 2016 Mar 1555
• Familial Hypercholesterolemia: Awareness, Appraisal, and Action.
  Genest Jacques et al. The Canadian journal of cardiology 2016 Nov
• Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
  Abul-Husn Noura S et al. Science (New York, N.Y.) 2016 Dec 354(6319)
• Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors.
  Arca Marcello et al. Atherosclerosis 2016 Sep
• Geisinger and Regeneron study finds life-threatening genetic disorder is substantially underdiagnosed 
  Geisinger Health System, December 22, 2016
• Knowing the Prevalence of Familial Hypercholesterolemia Matters.
  Goldberg Anne C et al. Circulation 2016 Mar 133(11) 1054-7
• Letter by Paton Regarding Article, "Knowing the Prevalence of Familial Hypercholesterolemia Matters".
  Paton David M et al. Circulation 2016 Jul 134(3) e17-8
• Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry.
  Saltijeral Adriana et al. Revista espanola de cardiologia (English ed.) 2016 Nov
• A novel approach to screening for familial hypercholesterolemia in a large public venue.
  Campbell Megan et al. Journal of community genetics 2016 Nov
• A qualitative study of patients' perceptions of the value of molecular diagnosis for familial hypercholesterolemia (FH).
  Hallowell Nina et al. Journal of community genetics 2016 Nov
• The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction.
  Rerup Sofie Aagaard et al. American heart journal 2016 Nov 18135-42
• The use of targeted exome sequencing in genetic diagnosis of young patients with severe hypercholesterolemia.
  Jiang Long et al. Scientific reports 2016 Nov 636823

more

---

Most Recent Scientific Publications from Weekly Horizon Scans

From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

• [Diagnosis and treatment of familial hypercholesterolemia in Spain: consensus document].
  Mata Pedro et al. Atencion primaria 2015 Jan 47(1) 56-65
• An Evidence-Based Guide to Cholesterol-Lowering Guidelines.
  Waters David D et al. The Canadian journal of cardiology 2016 Oct
• Genetic identification of familial hypercholesterolemia within a single U.S. health care system.
  Abul-Husn Noura S et al. Science (New York, N.Y.) 2016 Dec 354(6319)
• Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors.
  Arca Marcello et al. Atherosclerosis 2016 Sep
• Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥ 70 mg/dl despite maximal tolerated cholesterol lowering therapy.
  Glueck Charles J et al. Lipids in health and disease 2016 Mar 1555

more